PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 136 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $84,191,000 | +122.2% | 2,170,423 | +16.6% | 0.05% | +95.8% |
| Q4 2018 | $37,891,000 | -61.5% | 1,861,944 | -13.3% | 0.02% | -54.7% |
| Q3 2018 | $98,415,000 | -49.6% | 2,146,460 | -35.0% | 0.05% | -52.3% |
| Q2 2018 | $195,315,000 | -35.9% | 3,302,021 | -26.3% | 0.11% | -38.3% |
| Q1 2018 | $304,791,000 | -29.2% | 4,482,306 | +2.9% | 0.18% | -32.1% |
| Q4 2017 | $430,555,000 | +90.1% | 4,355,643 | +130.3% | 0.26% | +82.8% |
| Q3 2017 | $226,435,000 | +39.5% | 1,890,901 | +1.8% | 0.14% | +31.8% |
| Q2 2017 | $162,302,000 | +90571.5% | 1,857,631 | +77984.5% | 0.11% | +5400.0% |
| Q3 2015 | $179,000 | -35.4% | 2,379 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $277,000 | – | 2,379 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |